Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption

INTRODUCTION: Bile acid malabsorption (BAM) is a socially debilitating disease characterised by high stool frequency and urgency caused by a spillover of bile acids into the colon. Bile acid sequestrants (BASs) have limited therapeutic effect but represent the only available treatment option. Cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Kårhus, Martin Lund, Brønden, Andreas, Lyng Forman, Julie, Haaber, Anne, Vilsbøll, Tina, Sonne, David Peick, Knop, Filip Krag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871677/
https://www.ncbi.nlm.nih.gov/pubmed/33558360
http://dx.doi.org/10.1136/bmjopen-2020-044711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871677/
https://www.ncbi.nlm.nih.gov/pubmed/33558360
http://dx.doi.org/10.1136/bmjopen-2020-044711

Ejemplares similares